The markets entered September on a strong note. For the month ended September 10, the Nasdaq climbed an impressive 4.93 percent to lead the major indexes. The S&P 500 rose […]
Year: 2014
Global Momentum Guide for September 15, 2014
Click here to view the Global Momentum Guide for September 15, 2014 Weekly Sector Perspective Stocks slipped this week, with concerns over higher interest rates knocking both the bond and stock markets. […]
Market Perspective for September 12, 2014
The indexes lost ground today, pulling their weekly performance into negative territory. Overall, the S&P 500 Index lost 1.10 percent on the week, while the Dow Jones Industrial Average dropped 0.87 percent. The Russell 2000 retreated 0.81percent. The Nasdaq, which has been the strongest index recently, lost a modest 0.33 percent.
Apple (AAPL) unveiled its anticipated watch this week. Shares of Apple rallied strongly ahead of the news and then tumbled as traders sold the stock. Shares recovered later in the week and went on to finish higher. Since Apple is the largest stock in both the S&P 500 Index and the Nasdaq, it’s movement up, down and then up again helped make for a mildly choppy week for stocks.
The real action this week was in the currency markets. The Japanese yen broke to a new 52-week low versus the U.S. dollar and then continued falling. The euro finally stabilized after a scare earlier in the week, when traders saw a poll that showed the Scottish independence vote leaning towards the yes camp. The news weighed even more on the British pound, which for obvious reasons is first in line for any effects should Scotland decide to leave the UK next week.
The Australian dollar also fell this week, as part of a wider drop in industrial commodities. Iron ore and copper came under pressure as concerns about a slowdown in China picked up. The stronger U.S. dollar is also weighing on commodities. Between the losses in currency and commodity markets, the U.S. dollar is having one of its best streaks in almost two decades. That’s keeping U.S. assets attractive and drawing in investors from the developed world
The effects of the Federal Reserve’s taper may finally be hitting the bond markets though. Short-term yields have been increasing and long-term yields joined them this week. Junk bonds are also under pressure again after barely making a new high in late August. It hasn’t been a big or noisy move, but interest rates are quietly rising in the U.S., though mostly concentrated in shorter-term bonds. Europe had been helping to pull rates lower, since some of its sovereign bond yields are in negative territory, but the impact may be limited moving forward.
As we approach the mid-point of the month and look ahead to October, the U.S. remains the relatively attractive destination for investors. The economy is much stronger than Europe or Japan. Bond yields are significantly higher, the currency is strengthening and the stock market continues to perform well. The Fed’s exit from quantitative easing should support the dollar, while the European Central Bank and Bank of Japan move to weaken their currencies should work in concert to strengthen the dollar. Interest rates remain low and the very low rates in Europe could help keep domestic bond yields subdued, even though GDP growth is picking up. Stocks performance may be a bit more tempered moving forward, but the bull market still has a lot of factors working in its favor.
The Best Pharma ETF
The Best Pharma ETF
A Seeking Alpha Contribution
Summary
- PPH is a mega cap fund with foreign exposure.
 - IHE is a domestic fund with some small and mid-cap exposure.
 - XPH is a fund that equally weights across holdings and is relatively balanced across market cap.
 - PJP is the best performer since 2006.
 
Investors have four ETF options in the pharmaceutical sector with sufficient assets and trading volume. Which one is the best of the bunch? It turns out they all have unique properties, but one stands out from the pack due to its outperforming the group.
PowerShares Dynamic Pharmaceuticals (NYSEARCA:PJP)
PJP tracks the Intellidex index, one of the first “smart” indexes in the ETF market. The fund passively tracks the index, by criteria such as growth, valuation and momentum.
SPDR S&P Pharmaceuticals (NYSEARCA:XPH)
XPH tracks the S&P Pharmaceuticals Select Industry Index, a market cap weighted index. To continue reading, please Click Here.
*Please note, this article was written and published as a contribution for Seeking Alpha. To finish reading the article you will be redirected to their site.
REITs Attractive Even With Rising Rates
REITs Attractive Even With Rising Rates
A Seeking Alpha contribution
Summary
- A rapid increase in interest rates is a risk for REITs, not simply higher rates.
 - Rates will remain historically low for some time even after rate increases begin.
 - Economic growth and a bull market in stocks are bullish for REITs.
 
A low-yield environment has caused investors to search for financial instruments that provide a higher yield than bank savings and Treasury bonds, forcing them to take on more risk. While low interest rates have hurt investors, they are enabling real estate to reestablish a firm footing after the 2008 financial crisis. The strong growth in the U.S. economy along with a favorable supply-demand balance is driving an increased appetite for commercial real estate. The recovery is being led by a demand in multi-family housing and self-storage units, as well as a slight uptick in regional malls. The combination of low interest rates and economic growth has resulted in commercial real estate outperforming the broader U.S. stock market…. To continue reading, please Click Here.
*Please note, this article was written and published as a contribution for Seeking Alpha. To finish reading the article you will be redirected to their site.